EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Piperidine-derived resensitizers revive aminoglycoside capacity against persister cells of Pseudomonas aeruginosa in vivo

Yeseul Kim, Minju Kim, Haneun Lee, Areum Park, Su Yong Shim, Yura Lee, Kyungjin Lee, Soohyun Lee, Do Young Jin, Jun-Seob Kim, Dongeun Yong, Won-Gon Kim und 5 weitere

Drug Resistance Updates · 2026-11 · 89 · 101471

DOI: 10.1016/j.drup.2026.101471 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drug Resistance Updates, 2026-11. Verfasst von Yeseul Kim und 16 weiteren Autor:innen. Beteiligte Einrichtung: Infectious Disease Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), Daejeon 34141, Republic of Korea; Department of…. Hauptthemen laut MEDLINE: Pseudomonas aeruginosa, Anti-Bacterial Agents, Aminoglycosides, Piperidines. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Korea Research Institute of Bioscience & Biotechnology, National Research Foundation, Korea Ministry of Science and ICT.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Bacterial persister cells represent a major barrier to antimicrobial therapy by surviving lethal antibiotic exposure in a transient, non-genetic state and serving as a reservoir for recurrent infection. Although persister resensitization has emerged as a promising therapeutic concept, its mechanistic basis and in vivo applicability remain poorly defined. Here, we demonstrate that the piperidine-derived compound C10 functions as an antibiotic-resensitizing agent. In persister-state Escherichia coli, C10 increased ribosomal RNA promoter B-driven green fluorescent protein expression and chemical uptake, suggesting partial transcriptional and metabolic reactivation in persister cells. In clinically relevant persister cells of Pseudomonas aeruginosa, C10 restored aminoglycoside susceptibility and revived bactericidal capacity resulting in improved therapeutic efficacy in multiple murine infection models such as systemic sepsis, neutropenic thigh infection, and pneumonia. To improve translational feasibility, medicinal chemistry optimization identified KP35, a derivative with reduced mammalian cytotoxicity while retaining resensitization activity. Transcriptomic profiling revealed selective activation of nitrate respiration-associated pathways, consistent with respiratory and metabolic priming rather than global growth reactivation. Collectively, our findings establish chemical persister resensitization as a therapeutically actionable strategy for restoring antibiotic efficacy against bacterial persister cells and provide mechanistic insight into respiratory rewiring-mediated aminoglycoside resensitization.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pseudomonas aeruginosaAnti-Bacterial AgentsAminoglycosidesPiperidinesPseudomonas InfectionsAnimalsEscherichia coliMicrobial Sensitivity TestsMiceHumansGene Expression Regulation, Bacterial

Stichwörter der Autor:innen

AminoglycosidesAnd Respiratory primingAntibiotic resensitizationBacterial persisterPseudomonas aeruginosa

Substanzen

Anti-Bacterial AgentsAminoglycosidesPiperidines

Autor:innen und Institutionen

  • Infectious Disease Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), Daejeon 34141, Republic of Korea; Department of Functional Genomics, KRIBB School, University of Science and Technolo…
  • Infectious Diseases Therapeutic Research Center, Korea Research Institute of Chemical Technology (KRICT), Daejeon 34114, Republic of Korea; Department of Chemistry, Yonsei University, Seoul 03722, Republic of Korea.
  • Infectious Diseases Therapeutic Research Center, Korea Research Institute of Chemical Technology (KRICT), Daejeon 34114, Republic of Korea; Department of Chemistry, Hanyang University, Seoul 04763, Republic of Korea.
  • Infectious Diseases Therapeutic Research Center, Korea Research Institute of Chemical Technology (KRICT), Daejeon 34114, Republic of Korea.
  • Infectious Diseases Therapeutic Research Center, Korea Research Institute of Chemical Technology (KRICT), Daejeon 34114, Republic of Korea; Division of Medicinal Chemistry and Pharmacology, KRICT School, UST, Daejeon 34…
  • Infectious Disease Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), Daejeon 34141, Republic of Korea; Department of Biosystems and Bioengineering, KRIBB School, UST, Daejeon 34113, Repu…

Förderung

  • Korea Research Institute of Bioscience & Biotechnology
  • National Research Foundation
  • Korea Ministry of Science and ICT

Zitieren

APA

Kim, Y., Kim, M., Lee, H., Park, A., Shim, S. Y., Lee, Y., Lee, K., Lee, S., Jin, D. Y., Kim, J. S., Yong, D., Kim, W. G., Ryu, C. M., Lee, H., Seo, H. W., Kwak, J., & Kim, D. (2026). Piperidine-derived resensitizers revive aminoglycoside capacity against persister cells of Pseudomonas aeruginosa in vivo. Drug Resistance Updates, 89, 101471. https://doi.org/10.1016/j.drup.2026.101471

Vancouver

Kim Y, Kim M, Lee H, Park A, Shim SY, Lee Y, et al. Piperidine-derived resensitizers revive aminoglycoside capacity against persister cells of Pseudomonas aeruginosa in vivo. Drug Resistance Updates. 2026;89:101471. doi:10.1016/j.drup.2026.101471

BibTeX
@article{Kim2026,
  author = {Kim, Yeseul and Kim, Minju and Lee, Haneun and Park, Areum and Shim, Su Yong and Lee, Yura and Lee, Kyungjin and Lee, Soohyun and Jin, Do Young and Kim, Jun-Seob and Yong, Dongeun and Kim, Won-Gon and Ryu, Choong-Min and Lee, Hyuk and Seo, Hwi Won and Kwak, Jaesung and Kim, Dajeong},
  title = {Piperidine-derived resensitizers revive aminoglycoside capacity against persister cells of Pseudomonas aeruginosa in vivo},
  journal = {Drug Resistance Updates},
  year = {2026},
  volume = {89},
  pages = {101471},
  doi = {10.1016/j.drup.2026.101471}
}
Kostenlos starten →